Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

33
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
33
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

702
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
702
Diabetic Retinopathy01:27

Diabetic Retinopathy

55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

764
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defective queuosine and i6A/ms2i6A modification of tRNATyr cause frameshifting and protein aggregation.

Nucleic acids research·2026
Same author

Modulation of ion channels as emerging therapeutic targets in the treatment of diabetic neuropathy.

EXCLI journal·2026
Same author

Synthesis of N<i>-</i>alkylated hypoxanthine derivatives and their evaluation as antimicrobial agents.

Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes·2026
Same author

Incidence and outcomes of patients hospitalised with COPD in Greater Glasgow and Clyde, Scotland 2015-2022: a retrospective cohort study.

BMC pulmonary medicine·2026
Same author

Safety and effectiveness of ETHIZIA versus TachoSil for hemostasis during open liver surgery: a randomized controlled multicenter trial.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same author

Targeting excitatory/inhibitory neurotransmission by wogonin: integrated <i>In Silico</i> and <i>In Vivo</i> evidence in Parkinson's disease model.

Neurodegenerative disease management·2026

Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.6K

Diabetic peripheral neuropathy: current perspective and future directions.

Randhir Singh1, Lalit Kishore1, Navpreet Kaur1

  • 1M.M. College of Pharmacy, Maharishi Markandeshwar University, Mullana-Ambala, Haryana 133207, India.

Pharmacological Research
|December 31, 2013
PubMed
Summary

Diabetic neuropathy, a common diabetes complication, stems from metabolic disruptions and oxidative stress. Targeting these pathways may improve treatment, but a unified approach is needed for better outcomes.

Keywords:
Diabetic peripheral neuropathyHerbal interventionHyperglycemiaTherapeutic approaches

More Related Videos

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.1K
Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers
10:31

Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers

Published on: September 29, 2017

9.7K

Related Experiment Videos

Last Updated: May 4, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.6K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.1K
Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers
10:31

Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers

Published on: September 29, 2017

9.7K

Area of Science:

  • Neuroscience
  • Endocrinology
  • Metabolic Disorders

Background:

  • Diabetic neuropathy is a prevalent and complex complication of diabetes mellitus.
  • It affects both the peripheral nervous system's somatic and autonomic components.
  • Hyperglycemia-induced metabolic disruptions, including protein kinase C and polyol pathway alterations, are key contributors.

Purpose of the Study:

  • To review the complex pathophysiology of diabetic neuropathy.
  • To discuss current therapeutic strategies for managing diabetic neuropathy.
  • To explore future directions in the treatment of diabetic neuropathy.

Main Methods:

  • Literature review focusing on the pathogenesis of diabetic neuropathy.
  • Analysis of metabolic pathways implicated in diabetic neuropathy development.
  • Evaluation of existing and potential therapeutic interventions.

Main Results:

  • Oxidative stress, driven by metabolic pathway activation, is a central mechanism in hyperglycemia-induced nerve damage.
  • Therapeutic interventions targeting these metabolic pathways show promise but may have limited success if focused on single mechanisms.
  • Current treatments include glycemic control and symptomatic relief.

Conclusions:

  • Understanding the unifying role of oxidative stress is crucial for developing effective diabetic neuropathy treatments.
  • A multi-targeted therapeutic approach may be more successful than targeting single pathways.
  • Further research into novel therapeutic strategies is essential for improved patient outcomes.